Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease

Drugs targeting cardiovascular disease (CVD) can have negative consequences for liver function. Here, the authors combine genome wide analyses on 69,479 individuals to identify loss-of-function variants with beneficial effects on CVD-related traits without negative impacts on liver function.

Guardado en:
Detalles Bibliográficos
Autores principales: Jonas B. Nielsen, Oren Rom, Ida Surakka, Sarah E. Graham, Wei Zhou, Tanmoy Roychowdhury, Lars G. Fritsche, Sarah A. Gagliano Taliun, Carlo Sidore, Yuhao Liu, Maiken E. Gabrielsen, Anne Heidi Skogholt, Brooke Wolford, William Overton, Ying Zhao, Jin Chen, He Zhang, Whitney E. Hornsby, Akua Acheampong, Austen Grooms, Amanda Schaefer, Gregory J. M. Zajac, Luis Villacorta, Jifeng Zhang, Ben Brumpton, Mari Løset, Vivek Rai, Pia R. Lundegaard, Morten S. Olesen, Kent D. Taylor, Nicholette D. Palmer, Yii-Der Chen, Seung H. Choi, Steven A. Lubitz, Patrick T. Ellinor, Kathleen C. Barnes, Michelle Daya, Nicholas Rafaels, Scott T. Weiss, Jessica Lasky-Su, Russell P. Tracy, Ramachandran S. Vasan, L. Adrienne Cupples, Rasika A. Mathias, Lisa R. Yanek, Lewis C. Becker, Patricia A. Peyser, Lawrence F. Bielak, Jennifer A. Smith, Stella Aslibekyan, Bertha A. Hidalgo, Donna K. Arnett, Marguerite R. Irvin, James G. Wilson, Solomon K. Musani, Adolfo Correa, Stephen S. Rich, Xiuqing Guo, Jerome I. Rotter, Barbara A. Konkle, Jill M. Johnsen, Allison E. Ashley-Koch, Marilyn J. Telen, Vivien A. Sheehan, John Blangero, Joanne E. Curran, Juan M. Peralta, Courtney Montgomery, Wayne H-H Sheu, Ren-Hua Chung, Karen Schwander, Seyed M. Nouraie, Victor R. Gordeuk, Yingze Zhang, Charles Kooperberg, Alexander P. Reiner, Rebecca D. Jackson, Eugene R. Bleecker, Deborah A. Meyers, Xingnan Li, Sayantan Das, Ketian Yu, Jonathon LeFaive, Albert Smith, Tom Blackwell, Daniel Taliun, Sebastian Zollner, Lukas Forer, Sebastian Schoenherr, Christian Fuchsberger, Anita Pandit, Matthew Zawistowski, Sachin Kheterpal, Chad M. Brummett, Pradeep Natarajan, David Schlessinger, Seunggeun Lee, Hyun Min Kang, Francesco Cucca, Oddgeir L. Holmen, Bjørn O. Åsvold, Michael Boehnke, Sekar Kathiresan, Goncalo R. Abecasis, Y. Eugene Chen, Cristen J. Willer, Kristian Hveem
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/2eecf9230b454b46b95b45b0f20ddd2e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2eecf9230b454b46b95b45b0f20ddd2e
record_format dspace
spelling oai:doaj.org-article:2eecf9230b454b46b95b45b0f20ddd2e2021-12-02T13:24:23ZLoss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease10.1038/s41467-020-20086-32041-1723https://doaj.org/article/2eecf9230b454b46b95b45b0f20ddd2e2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-20086-3https://doaj.org/toc/2041-1723Drugs targeting cardiovascular disease (CVD) can have negative consequences for liver function. Here, the authors combine genome wide analyses on 69,479 individuals to identify loss-of-function variants with beneficial effects on CVD-related traits without negative impacts on liver function.Jonas B. NielsenOren RomIda SurakkaSarah E. GrahamWei ZhouTanmoy RoychowdhuryLars G. FritscheSarah A. Gagliano TaliunCarlo SidoreYuhao LiuMaiken E. GabrielsenAnne Heidi SkogholtBrooke WolfordWilliam OvertonYing ZhaoJin ChenHe ZhangWhitney E. HornsbyAkua AcheampongAusten GroomsAmanda SchaeferGregory J. M. ZajacLuis VillacortaJifeng ZhangBen BrumptonMari LøsetVivek RaiPia R. LundegaardMorten S. OlesenKent D. TaylorNicholette D. PalmerYii-Der ChenSeung H. ChoiSteven A. LubitzPatrick T. EllinorKathleen C. BarnesMichelle DayaNicholas RafaelsScott T. WeissJessica Lasky-SuRussell P. TracyRamachandran S. VasanL. Adrienne CupplesRasika A. MathiasLisa R. YanekLewis C. BeckerPatricia A. PeyserLawrence F. BielakJennifer A. SmithStella AslibekyanBertha A. HidalgoDonna K. ArnettMarguerite R. IrvinJames G. WilsonSolomon K. MusaniAdolfo CorreaStephen S. RichXiuqing GuoJerome I. RotterBarbara A. KonkleJill M. JohnsenAllison E. Ashley-KochMarilyn J. TelenVivien A. SheehanJohn BlangeroJoanne E. CurranJuan M. PeraltaCourtney MontgomeryWayne H-H SheuRen-Hua ChungKaren SchwanderSeyed M. NouraieVictor R. GordeukYingze ZhangCharles KooperbergAlexander P. ReinerRebecca D. JacksonEugene R. BleeckerDeborah A. MeyersXingnan LiSayantan DasKetian YuJonathon LeFaiveAlbert SmithTom BlackwellDaniel TaliunSebastian ZollnerLukas ForerSebastian SchoenherrChristian FuchsbergerAnita PanditMatthew ZawistowskiSachin KheterpalChad M. BrummettPradeep NatarajanDavid SchlessingerSeunggeun LeeHyun Min KangFrancesco CuccaOddgeir L. HolmenBjørn O. ÅsvoldMichael BoehnkeSekar KathiresanGoncalo R. AbecasisY. Eugene ChenCristen J. WillerKristian HveemNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Jonas B. Nielsen
Oren Rom
Ida Surakka
Sarah E. Graham
Wei Zhou
Tanmoy Roychowdhury
Lars G. Fritsche
Sarah A. Gagliano Taliun
Carlo Sidore
Yuhao Liu
Maiken E. Gabrielsen
Anne Heidi Skogholt
Brooke Wolford
William Overton
Ying Zhao
Jin Chen
He Zhang
Whitney E. Hornsby
Akua Acheampong
Austen Grooms
Amanda Schaefer
Gregory J. M. Zajac
Luis Villacorta
Jifeng Zhang
Ben Brumpton
Mari Løset
Vivek Rai
Pia R. Lundegaard
Morten S. Olesen
Kent D. Taylor
Nicholette D. Palmer
Yii-Der Chen
Seung H. Choi
Steven A. Lubitz
Patrick T. Ellinor
Kathleen C. Barnes
Michelle Daya
Nicholas Rafaels
Scott T. Weiss
Jessica Lasky-Su
Russell P. Tracy
Ramachandran S. Vasan
L. Adrienne Cupples
Rasika A. Mathias
Lisa R. Yanek
Lewis C. Becker
Patricia A. Peyser
Lawrence F. Bielak
Jennifer A. Smith
Stella Aslibekyan
Bertha A. Hidalgo
Donna K. Arnett
Marguerite R. Irvin
James G. Wilson
Solomon K. Musani
Adolfo Correa
Stephen S. Rich
Xiuqing Guo
Jerome I. Rotter
Barbara A. Konkle
Jill M. Johnsen
Allison E. Ashley-Koch
Marilyn J. Telen
Vivien A. Sheehan
John Blangero
Joanne E. Curran
Juan M. Peralta
Courtney Montgomery
Wayne H-H Sheu
Ren-Hua Chung
Karen Schwander
Seyed M. Nouraie
Victor R. Gordeuk
Yingze Zhang
Charles Kooperberg
Alexander P. Reiner
Rebecca D. Jackson
Eugene R. Bleecker
Deborah A. Meyers
Xingnan Li
Sayantan Das
Ketian Yu
Jonathon LeFaive
Albert Smith
Tom Blackwell
Daniel Taliun
Sebastian Zollner
Lukas Forer
Sebastian Schoenherr
Christian Fuchsberger
Anita Pandit
Matthew Zawistowski
Sachin Kheterpal
Chad M. Brummett
Pradeep Natarajan
David Schlessinger
Seunggeun Lee
Hyun Min Kang
Francesco Cucca
Oddgeir L. Holmen
Bjørn O. Åsvold
Michael Boehnke
Sekar Kathiresan
Goncalo R. Abecasis
Y. Eugene Chen
Cristen J. Willer
Kristian Hveem
Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease
description Drugs targeting cardiovascular disease (CVD) can have negative consequences for liver function. Here, the authors combine genome wide analyses on 69,479 individuals to identify loss-of-function variants with beneficial effects on CVD-related traits without negative impacts on liver function.
format article
author Jonas B. Nielsen
Oren Rom
Ida Surakka
Sarah E. Graham
Wei Zhou
Tanmoy Roychowdhury
Lars G. Fritsche
Sarah A. Gagliano Taliun
Carlo Sidore
Yuhao Liu
Maiken E. Gabrielsen
Anne Heidi Skogholt
Brooke Wolford
William Overton
Ying Zhao
Jin Chen
He Zhang
Whitney E. Hornsby
Akua Acheampong
Austen Grooms
Amanda Schaefer
Gregory J. M. Zajac
Luis Villacorta
Jifeng Zhang
Ben Brumpton
Mari Løset
Vivek Rai
Pia R. Lundegaard
Morten S. Olesen
Kent D. Taylor
Nicholette D. Palmer
Yii-Der Chen
Seung H. Choi
Steven A. Lubitz
Patrick T. Ellinor
Kathleen C. Barnes
Michelle Daya
Nicholas Rafaels
Scott T. Weiss
Jessica Lasky-Su
Russell P. Tracy
Ramachandran S. Vasan
L. Adrienne Cupples
Rasika A. Mathias
Lisa R. Yanek
Lewis C. Becker
Patricia A. Peyser
Lawrence F. Bielak
Jennifer A. Smith
Stella Aslibekyan
Bertha A. Hidalgo
Donna K. Arnett
Marguerite R. Irvin
James G. Wilson
Solomon K. Musani
Adolfo Correa
Stephen S. Rich
Xiuqing Guo
Jerome I. Rotter
Barbara A. Konkle
Jill M. Johnsen
Allison E. Ashley-Koch
Marilyn J. Telen
Vivien A. Sheehan
John Blangero
Joanne E. Curran
Juan M. Peralta
Courtney Montgomery
Wayne H-H Sheu
Ren-Hua Chung
Karen Schwander
Seyed M. Nouraie
Victor R. Gordeuk
Yingze Zhang
Charles Kooperberg
Alexander P. Reiner
Rebecca D. Jackson
Eugene R. Bleecker
Deborah A. Meyers
Xingnan Li
Sayantan Das
Ketian Yu
Jonathon LeFaive
Albert Smith
Tom Blackwell
Daniel Taliun
Sebastian Zollner
Lukas Forer
Sebastian Schoenherr
Christian Fuchsberger
Anita Pandit
Matthew Zawistowski
Sachin Kheterpal
Chad M. Brummett
Pradeep Natarajan
David Schlessinger
Seunggeun Lee
Hyun Min Kang
Francesco Cucca
Oddgeir L. Holmen
Bjørn O. Åsvold
Michael Boehnke
Sekar Kathiresan
Goncalo R. Abecasis
Y. Eugene Chen
Cristen J. Willer
Kristian Hveem
author_facet Jonas B. Nielsen
Oren Rom
Ida Surakka
Sarah E. Graham
Wei Zhou
Tanmoy Roychowdhury
Lars G. Fritsche
Sarah A. Gagliano Taliun
Carlo Sidore
Yuhao Liu
Maiken E. Gabrielsen
Anne Heidi Skogholt
Brooke Wolford
William Overton
Ying Zhao
Jin Chen
He Zhang
Whitney E. Hornsby
Akua Acheampong
Austen Grooms
Amanda Schaefer
Gregory J. M. Zajac
Luis Villacorta
Jifeng Zhang
Ben Brumpton
Mari Løset
Vivek Rai
Pia R. Lundegaard
Morten S. Olesen
Kent D. Taylor
Nicholette D. Palmer
Yii-Der Chen
Seung H. Choi
Steven A. Lubitz
Patrick T. Ellinor
Kathleen C. Barnes
Michelle Daya
Nicholas Rafaels
Scott T. Weiss
Jessica Lasky-Su
Russell P. Tracy
Ramachandran S. Vasan
L. Adrienne Cupples
Rasika A. Mathias
Lisa R. Yanek
Lewis C. Becker
Patricia A. Peyser
Lawrence F. Bielak
Jennifer A. Smith
Stella Aslibekyan
Bertha A. Hidalgo
Donna K. Arnett
Marguerite R. Irvin
James G. Wilson
Solomon K. Musani
Adolfo Correa
Stephen S. Rich
Xiuqing Guo
Jerome I. Rotter
Barbara A. Konkle
Jill M. Johnsen
Allison E. Ashley-Koch
Marilyn J. Telen
Vivien A. Sheehan
John Blangero
Joanne E. Curran
Juan M. Peralta
Courtney Montgomery
Wayne H-H Sheu
Ren-Hua Chung
Karen Schwander
Seyed M. Nouraie
Victor R. Gordeuk
Yingze Zhang
Charles Kooperberg
Alexander P. Reiner
Rebecca D. Jackson
Eugene R. Bleecker
Deborah A. Meyers
Xingnan Li
Sayantan Das
Ketian Yu
Jonathon LeFaive
Albert Smith
Tom Blackwell
Daniel Taliun
Sebastian Zollner
Lukas Forer
Sebastian Schoenherr
Christian Fuchsberger
Anita Pandit
Matthew Zawistowski
Sachin Kheterpal
Chad M. Brummett
Pradeep Natarajan
David Schlessinger
Seunggeun Lee
Hyun Min Kang
Francesco Cucca
Oddgeir L. Holmen
Bjørn O. Åsvold
Michael Boehnke
Sekar Kathiresan
Goncalo R. Abecasis
Y. Eugene Chen
Cristen J. Willer
Kristian Hveem
author_sort Jonas B. Nielsen
title Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease
title_short Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease
title_full Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease
title_fullStr Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease
title_full_unstemmed Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease
title_sort loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/2eecf9230b454b46b95b45b0f20ddd2e
work_keys_str_mv AT jonasbnielsen lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT orenrom lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT idasurakka lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT sarahegraham lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT weizhou lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT tanmoyroychowdhury lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT larsgfritsche lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT sarahagaglianotaliun lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT carlosidore lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT yuhaoliu lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT maikenegabrielsen lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT anneheidiskogholt lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT brookewolford lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT williamoverton lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT yingzhao lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT jinchen lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT hezhang lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT whitneyehornsby lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT akuaacheampong lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT austengrooms lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT amandaschaefer lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT gregoryjmzajac lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT luisvillacorta lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT jifengzhang lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT benbrumpton lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT mariløset lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT vivekrai lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT piarlundegaard lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT mortensolesen lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT kentdtaylor lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT nicholettedpalmer lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT yiiderchen lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT seunghchoi lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT stevenalubitz lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT patricktellinor lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT kathleencbarnes lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT michelledaya lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT nicholasrafaels lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT scotttweiss lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT jessicalaskysu lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT russellptracy lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT ramachandransvasan lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT ladriennecupples lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT rasikaamathias lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT lisaryanek lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT lewiscbecker lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT patriciaapeyser lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT lawrencefbielak lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT jenniferasmith lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT stellaaslibekyan lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT berthaahidalgo lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT donnakarnett lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT margueriterirvin lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT jamesgwilson lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT solomonkmusani lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT adolfocorrea lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT stephensrich lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT xiuqingguo lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT jeromeirotter lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT barbaraakonkle lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT jillmjohnsen lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT allisoneashleykoch lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT marilynjtelen lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT vivienasheehan lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT johnblangero lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT joanneecurran lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT juanmperalta lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT courtneymontgomery lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT waynehhsheu lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT renhuachung lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT karenschwander lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT seyedmnouraie lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT victorrgordeuk lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT yingzezhang lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT charleskooperberg lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT alexanderpreiner lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT rebeccadjackson lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT eugenerbleecker lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT deborahameyers lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT xingnanli lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT sayantandas lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT ketianyu lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT jonathonlefaive lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT albertsmith lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT tomblackwell lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT danieltaliun lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT sebastianzollner lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT lukasforer lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT sebastianschoenherr lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT christianfuchsberger lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT anitapandit lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT matthewzawistowski lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT sachinkheterpal lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT chadmbrummett lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT pradeepnatarajan lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT davidschlessinger lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT seunggeunlee lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT hyunminkang lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT francescocucca lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT oddgeirlholmen lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT bjørnoasvold lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT michaelboehnke lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT sekarkathiresan lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT goncalorabecasis lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT yeugenechen lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT cristenjwiller lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
AT kristianhveem lossoffunctiongenomicvariantshighlightpotentialtherapeutictargetsforcardiovasculardisease
_version_ 1718393085494296576